The use of diagnoses related to tobacco use in the Czech Republic
Authors:
Miroslav Zvolský 1; Blanka Nechanská 1; Eva Králíková 2
Authors place of work:
Centrum pro závislé na tabáku
III. interní klinika, 1. lékařská fakulta Univerzity Karlovy a VFN, Praha
; Ústav zdravotnických informací a statistiky České republiky, Praha
1; Ústav hygieny a epidemiologie, 1. lékařská fakulta Univerzity Karlovy a VFN
2
Published in the journal:
Čas. Lék. čes. 2012; 151: 573-578
Category:
Original Article
Summary
Background:
According to the International Statistical Classification of Diseases and Related Health Problems 10th Revision, tobacco dependence is coded by group F17 – Mental and behavioral disorders due to use of tobacco. There are other codes for diagnoses and conditions associated with tobacco use. The aim of our analysis was to determine how often these codes are reported in clinical practice.
Methods and results:
We observed the incidence of diagnoses F17, P04.2, Z72.0 or T65.2 in years 2002–2011 in hospitalized patients and the F17 diagnosis in patients of psychiatric health facilities. According to data from the Institute of Health Information and Statistics of the Czech Republic diagnoses indicating smoking patients were reported in 1.5% of hospitalized patients in 2011, although the prevalence of smoking in the population is around 30% in last 15 years. Smoking-related diagnoses were reported in 2.1% of cases in Internal medicine departments. Codes F17, T65.2 and Z72.0 occurred as an accessory diagnose in vascular brain disease in 1.8% of hospitalizations and for respiratory tract neoplasms (dg. C32–C34) it was 7.1% of hospitalizations.
Conclusions:
These results demonstrate the underestimation of the importance of smoking and its relationship to clinical disciplines. Although it is one of the most common diseases in the population with a direct relation to fatal diseases of civilization, the information on its incidence is not used in clinical practice.
Key words:
nicotine dependence, passive smoking, International Classification of Diseases, hospitalization, morbidity.
Zdroje
1. Mezinárodní statistická klasifikace nemocí a přidružených zdravotních problémů, 10. revize, druhé aktualizované vydání. Světová zdravotnická organizace. Praha: Ústav zdravotnických informací a statistiky ČR 2011. http://www.uzis.cz/system/files/ mkn-tabelarni-cast_1-1-2012.pdf.
2. Sovinová H, Sadílek P, Csémy L. Vývoj prevalence kuřáctví v dospělé populaci ČR, názory a postoje občanů ČR k problematice kouření (období 1997–2011) – výzkumná zpráva. Praha: SZU 2012.
3. Fiore MC, Bailey WC, Cohen SJ, et al. Treating tobacco use and dependence: clinical practice guideline. Rockville, MD, US: Department of Health and Human Services 2008
4. Štěpánková L, Králíková E. Léčba závislosti na tabáku u pacientů s psychiatrickou komorbiditou. Psychiatrie pro praxi 2010; 11(2): 66–69.
5. Haire-Joshu D, Glasgow RE, Tibbs TL; American Diabetes Association. Smoking and diabetes. Diabetes Care 2004; 27(Suppl 1): S74–75.
6. Wolf PA, D’Agostino RB, Kannel WB, Bonita R, Belanger AJ. Cigarette smoking as a risk factor for stroke: the framingham study. JAMA 1988; 259(7): 1025–1029.
7. Ockene JK, Kuller LH, Svendsen KH, Meilahn E. The relationship of smoking cessation to coronary heart disease and lung cancer in the Multiple Risk Factor Intervention Trial (MRFIT). Am J Public Health. 1990; 80: 954–958.
8. Doll R, Hill AB. Smoking and Carcinoma of the Lung. Br Med J 1950; 2(4682): 739–748.
9. Mravčík V, Nechanská B, Šťastná L. Ambulantní péče o uživatele a závislé na návykových látkách v ČR ve zdravotnické statistice od r. 1963. Epidemiologie, Mikrobiologie, Imunologie 2011a; 64–73.
10. Nechanská B, Mravčík V, Šťastná L, Brožová J. Uživatelé alkoholu a dalších drog ve zdravotnické statistice od r. 1959. Praha: Úřad vlády ČR a ÚZIS ČR 2011.
11. Mravčík V, Nechanská B, Šťastná L. Lůžková péče o uživatele a závislé na návykových látkách v ČR ve zdravotnické statistice od r. 1959. Epidemiologie, Mikrobiologie, Imunologie 2011b; 23–31.
Štítky
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistČlánok vyšiel v časopise
Journal of Czech Physicians
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Spasmolytic Effect of Metamizole
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
- Metamizole in perioperative treatment in children under 14 years – results of a questionnaire survey from practice
Najčítanejšie v tomto čísle
- Thalidomide epidemics – 50 years after
- Acute multiple organ failure after endoscopic polypectomy
- Role of infection in the pathogenesis of obesity
- Instruction to the Authors the Journal of Czech Physicians